Concepedia

Shingo Kozono

SK

Statistics

Publications

28

Citations

1.5K

H-Index

21

Active since

2011

Affiliations

Kyushu University(Current)

Beth Israel Deaconess Medical Center

Tokyo Medical University

Harvard University

Translational Therapeutics (United States)

Shingo Kozono is an author at Kyushu University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2011–2025

28

Publications

28

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

Shuo Wei, Shingo Kozono, Lev M. Kats et al. · Nature Medicine · 2015 · 268 citations · Full text

, , +10

Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells

Shingo Kozono, Kenoki Ohuchida, Daiki Eguchi et al. · Cancer Research · 2013 · 196 citations

, , +17

Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells

Shingo Kozono, Yu‐Min Lin, Hyuk‐Soo Seo et al. · Nature Communications · 2018 · 161 citations · Full text

, , +17

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 148 citations · Full text

, , +14

Identification of a potent and selective covalent Pin1 inhibitor

Benika J. Pinch, Zainab M. Doctor, Behnam Nabet et al. · Nature Chemical Biology · 2020 · 85 citations · Full text

, , +11

1–5 of 28